Embecta Corp./$EMBC
EMBC jumps after reporting Q3 FY25 results with revenue up 8.4% and adjusted EPS of $1.12 topping consensus and raising fiscal 2025 adjusted EPS guidance to $2.90–$2.95.
13 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
Ticker
$EMBC
Sector
Health
Primary listing
Employees
2,100
Headquarters
Website
Embecta Corp. Metrics
BasicAdvanced
$605M
11.61
$0.89
1.19
$0.60
5.79%
Price and volume
Market cap
$605M
Beta
1.19
52-week high
$21.23
52-week low
$9.20
Average daily volume
600K
Dividend rate
$0.60
Financial strength
Current ratio
2.481
Quick ratio
1.589
Long term debt to equity
-210.459
Total debt to equity
-210.744
Dividend payout ratio (TTM)
65.91%
Interest coverage (TTM)
0.38%
Profitability
EBITDA (TTM)
83.8
Gross margin (TTM)
64.06%
Net profit margin (TTM)
4.89%
Operating margin (TTM)
4.07%
Effective tax rate (TTM)
4.17%
Revenue per employee (TTM)
$510,000
Management effectiveness
Return on assets (TTM)
2.53%
Return on equity (TTM)
-7.01%
Valuation
Price to earnings (TTM)
11.612
Price to revenue (TTM)
0.556
Price to book
-0.82
Price to tangible book (TTM)
-0.8
Price to free cash flow (TTM)
15.123
Free cash flow yield (TTM)
6.61%
Free cash flow per share (TTM)
0.685
Dividend yield (TTM)
5.79%
Forward dividend yield
5.79%
Growth
Revenue change (TTM)
-4.68%
Earnings per share change (TTM)
-26.96%
3-year revenue growth (CAGR)
-2.36%
3-year earnings per share growth (CAGR)
-48.85%
What the Analysts think about Embecta Corp.
Analyst ratings (Buy, Hold, Sell) for Embecta Corp. stock.
Embecta Corp. Financial Performance
Revenues and expenses
Embecta Corp. Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Aug29
Embecta Corp.
Dividend·Ex-dividend
Sept15
Embecta Corp.
Dividend·Payment
$0.15Per share
FAQs
What’s the current market cap for Embecta Corp. stock?
Embecta Corp. (EMBC) has a market cap of $605M as of August 09, 2025.
What is the P/E ratio for Embecta Corp. stock?
The price to earnings (P/E) ratio for Embecta Corp. (EMBC) stock is 11.61 as of August 09, 2025.
Does Embecta Corp. stock pay dividends?
Yes, the Embecta Corp. (EMBC) stock pays dividends to shareholders. As of August 09, 2025, the dividend rate is $0.6 and the yield is 5.79%. Embecta Corp. has a payout ratio of 65.91% on a trailing twelve-month basis.
When is the next Embecta Corp. dividend payment date?
The next Embecta Corp. (EMBC) dividend payment is scheduled for September 15, 2025.
What is the beta indicator for Embecta Corp.?
Embecta Corp. (EMBC) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.